West Pharmaceutical Services (WST) to Release Earnings on Thursday

West Pharmaceutical Services (NYSE:WST - Get Free Report) is expected to issue its Q2 2025 quarterly earnings data before the market opens on Thursday, July 24th. Analysts expect the company to announce earnings of $1.51 per share and revenue of $725.11 million for the quarter. West Pharmaceutical Services has set its FY 2025 guidance at 6.150-6.350 EPS.

West Pharmaceutical Services (NYSE:WST - Get Free Report) last posted its earnings results on Thursday, April 24th. The medical instruments supplier reported $1.45 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.22 by $0.23. The business had revenue of $698.00 million for the quarter, compared to analysts' expectations of $685.24 million. West Pharmaceutical Services had a net margin of 16.13% and a return on equity of 18.23%. The business's revenue for the quarter was up .4% compared to the same quarter last year. During the same period in the prior year, the company posted $1.56 EPS. On average, analysts expect West Pharmaceutical Services to post $7 EPS for the current fiscal year and $8 EPS for the next fiscal year.

West Pharmaceutical Services Price Performance

Shares of West Pharmaceutical Services stock traded down $2.58 on Thursday, hitting $221.80. 532,410 shares of the company traded hands, compared to its average volume of 735,424. The firm's 50-day simple moving average is $217.88 and its 200 day simple moving average is $243.92. The company has a current ratio of 2.77, a quick ratio of 2.03 and a debt-to-equity ratio of 0.08. The company has a market cap of $15.94 billion, a P/E ratio of 34.82, a P/E/G ratio of 5.44 and a beta of 1.09. West Pharmaceutical Services has a 12-month low of $187.43 and a 12-month high of $352.33.

West Pharmaceutical Services Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, August 6th. Stockholders of record on Wednesday, July 30th will be given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 0.38%. The ex-dividend date is Wednesday, July 30th. West Pharmaceutical Services's dividend payout ratio (DPR) is currently 13.19%.

Analyst Ratings Changes

WST has been the topic of several research reports. Stephens upgraded shares of West Pharmaceutical Services to a "strong-buy" rating in a research report on Monday, April 21st. Citigroup restated a "buy" rating on shares of West Pharmaceutical Services in a research report on Thursday, May 22nd. Finally, Barclays began coverage on shares of West Pharmaceutical Services in a research report on Tuesday, June 24th. They set an "equal weight" rating and a $245.00 price objective on the stock. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and a consensus target price of $320.00.

Institutional Investors Weigh In On West Pharmaceutical Services

A number of large investors have recently added to or reduced their stakes in WST. Acadian Asset Management LLC grew its holdings in West Pharmaceutical Services by 14.1% in the 1st quarter. Acadian Asset Management LLC now owns 1,271 shares of the medical instruments supplier's stock worth $284,000 after acquiring an additional 157 shares during the last quarter. Empowered Funds LLC grew its holdings in West Pharmaceutical Services by 16.1% in the 1st quarter. Empowered Funds LLC now owns 1,611 shares of the medical instruments supplier's stock worth $361,000 after acquiring an additional 224 shares during the last quarter. Finally, Intech Investment Management LLC grew its holdings in West Pharmaceutical Services by 27.7% in the 1st quarter. Intech Investment Management LLC now owns 6,020 shares of the medical instruments supplier's stock worth $1,348,000 after acquiring an additional 1,307 shares during the last quarter. Institutional investors own 93.90% of the company's stock.

About West Pharmaceutical Services

West Pharmaceutical Services, Inc designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products.